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ABSTRACT
Recent data showed that p53 stimulates the expres-
sion of genes encoding not only pro- but also
antioxidant enzymes. It was suggested that antiox-
idant genes could be induced under physiologic
levels of stress while the prooxidant ones respond
to higher level of stress. Results presented in this
article illustrate an additional degree of complexity.
We show that the expression of Haeme-oxygenase 1
(HO-1), a stress-inducible gene that codes for an
enzyme having antioxidant properties, is stimulated
in a p53-dependent manner in the thymus and spleen
of irradiated mice. We prove that HO-1 is a direct p53
target gene by showing that the p53RE identified
within human and mouse genes is specifically bound
by p53. The threshold of irradiation dose required
to induce a significant response of HO-1 in the
lymphoid organs of the irradiated mice is higher
than that for Waf1/p21 that encodes an universal
inhibitor of cell cycle. Moreover, induction of HO-1
occurs later than that of Waf1/p21. Finally, the higher
stimulation of HO-1 is reached when Waf1/p21
stimulation starts to decrease.
INTRODUCTION
The toxicological mechanism of ionizing radiation is
generally accepted to be mediated primarily by generation
of reactive oxygen species (ROS). Based on a number of
observations, it was suggested that ROS are the common
mediators of apoptosis (1,2). Several mechanisms by
which ROS could induce apoptosis have been proposed.
(i) ROS act on mitochondria, causing a disruption of
the mitochondrial membrane potential and subsequently
the release of cytochrome c; (ii) ROS up-regulate the
expression of Fas and FasL and (iii) ROS modify the
activity of transcription factors involved in the cell death
and survival pathways [references in (2)].
Many of the signalling pathways activated by ionizing
radiation converge on p53, a protein encoded by the
tumour suppressor gene p53, whose major function is to
protect organisms from proliferation of potentially
tumourigenic cells. Post-translational modiﬁcations of
p53 in response to ionizing radiation lead to the activation
of its principal property that is to recognize a speciﬁc
DNA motif leading to the transcriptional stimulation of
the genes having such a p53 responsive element (p53RE)
within their promoter or intronic sequences (3–5). Global
mapping of transcription factor binding sites using
chromatin-immunoprecipitation-based techniques placed
the number of human genes potentially transactivated by
p53 between 542 (6) and 1600 (7). Among them, more
than one hundred have been functionally characterized.
A number of these genes involved in DNA repair,
regulation of cell cycle and apoptosis, could account for
the tumour suppression activity of p53 [references in (8,9)].
More recently, p53 target genes involved in the regulation
of glucose metabolism and oxidative stress have also been
identiﬁed [references in (10)]
Earlier data showed that the extent of p53-induced
apoptosis can be modulated by decreasing or increasing
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Analysis of Gene Expression (SAGE) in the colorectal
cancer line DLD-1 forced to express wt-p53 led Polyak
et al. to identify, for the ﬁrst time, a stimulation (>10 fold)
of several genes predicted to encode proteins that could
generate or respond to oxidative stress (13). At least one,
PIG3, appears to be directly regulated by p53 through
a p53RE element located in the promoter. The expression
of PIG3 is also stimulated in response to g-irradiation in
a number of transformed cell lines expressing wt-p53 (14).
PIG6 is another gene whose expression was found to
be stimulated in DLD-1 cells infected by recombinant
adenovirus expressing wt-p53. This gene encodes
a mitochondrial proline oxydase (POX) that mediates
the reversible conversion of proline to pyrroline-
5-carboxylate (P5C) with the concomitant transfer of
electrons to cytochrome c (13,15). Using doxorubicin to
initiate p53-dependent apoptosis, Donald et al. (15) have
shown that the expression of POX is up-regulated in a
time- and dose-dependent manner in another p53-wt
human colon cancer cell line (LoVo). The p53-dependent
stimulation of POX catalyses the proline-dependent
ROS generation suggesting again that ROS could act as
a downstream mediator of p53-induced apoptosis.
The ferrodoxine reductase gene (FRDX) is another
redox-related gene that was found to be up-regulated in
HCT116 carcinoma cells in response to endogenous
wt-p53 activation by 5-ﬂuoruracil (16). A p53RE element
has been recognized within the promoter sequence
identifying FRDX as a direct p53 target gene (16,17).
FRDX encodes a mammalian mitochondrial cytochrome
P-450 NADPH reductase. It has been shown that its over-
expression sensitizes HCT116 cells to apoptosis induced
by ROS-producing agents such as hydrogen peroxide
(H2O2) or doxorubicin (17).
More recent evidence suggests that p53 could also
play a role in antioxidant metabolism by inducing the
expression of proteins that function to lower ROS level.
ROS levels are normally controlled by the antioxidant
defence system including low and high molecular
weight components. Among them, superoxide dismutase
(SOD), glutathione peroxidase (GPx) and catalase play
a central role (18). The GPX1 gene that encodes
glutathione peroxidase-1 has been characterized as
a direct p53 target gene (19). But the SOD2 gene that
encodes the mitochondrial MnSOD enzyme has been
found to be either up- or down-regulated by p53,
depending on the context (20–22). The aldehyde deshy-
drogenase 4 (ALDH4), another gene encoding an anti-
oxidant enzyme has also been identiﬁed as a p53 target
gene (23). It encodes a mitochondrial-matrix NAD
+-
dependent enzyme. Inactivation of ALDH4 enhances p53-
dependent apoptosis, and its forced expression reduces
intracellular ROS levels (23).
In the same vein, expression of two mammalian sestrin
homologs, SESN1 and SESN2 that encode PA26 and
Hi95, is stimulated by p53 (24). These products have been
reported to be essential for regeneration of overoxidized
peroxiredoxins, the enzymes involved in the decomposi-
tion of H2O2 (25). Finally, TIGAR (TP53-induced
glycolysis and apoptosis regulator), a novel p53 target
gene, selectively inhibits ROS-sensitive apoptosis (26).
The fact that p53 can stimulate the expression of pro-
and antioxidant genes strongly suggests that p53 could
have opposing roles in the regulation of ROS depending
on the nature and the intensity of the stress, and on the
cellular context. As most of the published data refer to
experiments performed with tumour cell lines, we wanted
to analyse the p53-dependent regulation of stress-related
genes in a physiological cell environment in response to
a genotoxic stress that induces apoptosis speciﬁcally in p53
positive cells. It is well known that p53 is absolutely
required for irradiation-induced apoptosis in thymus and
spleen, both in vitro and in vivo (27–29). We therefore used
thymus and spleen obtained from whole body irradiated
p53+/+ and p53 /  mice as a source of diﬀerentially
expressed mRNA. We report that the stimulation Haeme-
oxygenase 1 (HO-1) in response to g-irradiation is directly
under the control of the p53 gene.
MATERIALS AND METHODS
Cells and theirtreatment
U-2OS and MCF-7 cells are derived from a human
osteosarcoma and a human breast carcinoma, respec-
tively. SKNSH-DDp53 and SKNSH-CMVNeo cell lines,
generously provided by Dr S. Lain, have been described
previously (30). They are derived from SK-N-SH neuro-
blastoma cells transfected with plasmids pCMVN
eop53DD and pCMV-Neo, respectively. pCMVN
eop53DD encodes the p53DD truncated protein that
includes the mouse p53 amino acid residues 1–14
and 302–390 (31). MCF-7/R-A1 cells, a gift from
Dr S. Chouaib, was obtained from MCF-7 by continuous
exposure to increasing doses of TNF-a (32). This cell line
expresses a p53 mutated at amino acid residue 280
(R!K). Cells were maintained at 378C in DMEM
(U-2OS, MCF-7, SKNSH-DDp53, SKNSH-CMVNeo)
or RPMI (MCF-7/R-A1) supplemented with 10% fetal
calf serum, and 100U/ml of penicillin and 100mg/ml
streptomycin. The SKNSH-DDp53 and SKNSH-
CMVNeo cells were maintained at 0.5mg/ml G418.
Plasmids
pGL3-E1bTATA (pluc-min) ﬁreﬂy luciferase reporter,
which contains a E1B minimal promoter upstream of
the luciferase coding sequence, is the reporter plasmid
used to measure the basal luciferase activity (33). The
pGL3-HO1 plasmid was obtained by inserting between
the HindIII and NcoI sites of pluc.min, a fragment of
the mouse HO-1 50non-translated sequence, obtained
by PCR amplifcation using the oligonucleotide pair [CT
GAAGCTTACGGTCTCCAGTCGCCTCCAG]/[CGTA
CCATGGTCATCACCGGACTGGGCTAGTTC]. The
recognition sequences of HindIII and NcoI restriction
enzymes are underlined. The ampliﬁed sequence of 151bp
encompasses the HO-1 50non-translated sequence from nt
 131 to nt +2 (+1 accounting for the A of the ATG
initiation codon) including the putative p53-responsive
element (Table 1). The cloned ampliﬁed fragment was
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pGL3-HO1mut plasmid was obtained from pGL3-HO1
by PCR-directed mutagenesis by introducing three
point mutations within the second decamer of the
p53-responsive element (Figure 3). The sequence of the
mutated fragment was veriﬁed. The pDDm-TO was
obtained by inserting the sequence that encodes the
mouse p53DD truncated protein into the Invitrogen
vector pcDNA4/TO/B.
Mice and irradiation
Animal procedures were carried out in accordance with
French Government regulations. The p53 /  and
p53+/+ C57BL/6 mice studied were progeny of p53
heterozygote animals obtained from IFFA-CREDO
(Orle ´ ans, France). The genotype background was deter-
mined by PCR ampliﬁcation of genomic DNA extracted
from tail biopsies as described previously (34). Six- to
eight-week-old mice were given whole-body g-irradiation
at the doses indicated from a
137Caesium source at a dose
rate of 0.2Gy/min (IBL 637, CisBio International).
Control and irradiated animals were sacriﬁced at the
time intervals indicated. Tissues were harvested and snap
frozen in liquid nitrogen and kept at  808C until used.
Microarray analysis
We used cDNA arrays of mouse stress/toxicology genes
(140 genes) spotted on nylon membrane (Atlas
TM ﬁlter
arrays, Clontech, Palo Alto, CA, USA). The ﬁlters include
also nine housekeeping control cDNA and negative
controls (M13 mp18(+) strand DNA, lambda DNA,
pUC18 DNA). The complete list of the cDNA and control
as well as their accession number is available on the web
(http://www.clonteh.com/atlas/genelists/index.html).
Total RNA was isolated using RNA-plus (kit RNA-plus;
Appligene) and potentially contaminating DNA was
removed by treating with RNAse-free DNAse I (RQ1,
RNAse-free DNAse Promega 1U/ml). Labelled cDNA
probe synthesis, microarray hybridization and wash steps
were performed according to the manufacturer’s recom-
mendations. Brieﬂy,
32P-labelled cDNA probes were
generated by reverse transcription of 2–5mg of each
DNAse I-treated total RNA sample in the presence of
[a
32P] dATP (3000Ci/mmol, 10mCi/ml; NEN) and
puriﬁed by spin column chromatography (Nucleospin
Extraction Kit; Clontech). Microarray hybridizations
were carried out on microarray ﬁlters with
32P-labelled
probe (1–3 10
6c.p.m.) in 6ml ExpressHyb
TM hybridiza-
tion solutions (Clontech) supplemented with heat-
denatured sheared salmon testes DNA (100mg/ml), in
roller bottles, in a hybridization incubator, at 688C
overnight. After extensive washing (three times with
2 SSC, 1% SDS, and once with 0.1  SSC, 0.5% SDS
each for 30min at 688C, once with 2 SSC for 5min at
room temperature), damp membranes were sealed in a
plastic wrap and autoradiographed in phosphorimager
cassettes for 5 days. The cDNA microarray autoradio-
grams were scanned with ImageQuant (Molecular
Dynamics, Sunnyvale, CA, USA) and the images were
analysed using the AtlasImage 2.0 software (Clontech,
USA). The background was calculated using default
external background calculation, which takes into con-
sideration the background signals at blank space between
the diﬀerent panels of the arrays. Signal threshold was set
as background-based signal threshold. The signal inten-
sities were normalized globally using the sum method
(AtlasImage, Clontech, USA).
Quantitative RT-PCR
Total RNA was prepared using the RNA-plus solution
(Bioprobe) as previously described (34). RNA (30mg) was
incubated 30min at 378C with 1 U DNAse–RNAse-free
(Boehringer) and 40 U RNAsine (Promega) in a ﬁnal
volume of 30ml. Following this treatment, RNA was
heated 2min at 958C, and then ice cooled. Reverse
transcription was performed on 3mg total RNA in the
presence of 12ml buﬀer RTX5 (GibcoBRL), 60U
RNAsine (Promega), 3ml of a mixture of the four
dNTPs (20mM each), 150ng of random primers
(Invitrogen) and 15U of AMV reverse transcriptase
(Promega) in a ﬁnal volume of 60ml. After an incubation
of 30min at 428C, additional 15U of AMV reverse
transcriptase (Promega) were added and incubation was
prolonged for 30min at 428C. At the end of the reaction,
AMV was heat inactivated 2min at 958C. Real-time PCR
was done using FastStart DNA Master SYBR Green I kit
and the LightCycler apparatus according to the protocol
provided by the manufacturer (Roche Molecular
Biochemicals). For each gene the sequence of primer
pairs and the annealing temperature are given in Table 1.
Luciferase assay
Cells (2 10
5) were plated in 6-well plates (Falcon) and
transfected with 200ml of DNA-calcium phosphate
Table 1. Real-time PCR analysis: sequence of the oligonucleotide pairs, annealing temperature, and product size
Genes Species Acc number Primer pairs Ta(8C)
a Size(bp)
b
GAPDH Murine BC083079 F CATGGCCTTCCGTGTTCCTA R TGCCTGCTTCACCACCTTCT 60 105
Human NM_002046 F AGCTCACTGGCATGGCCTTC R ACGCCTGCTTCACCACCTTC 60 117
HO-1 Murine NM_010442 F GGAGATAGAGCGCAACAAGC R CCATACCAGAAGGCCATGTC 60 105
Human NM_002133 F CCAGTGCCACCAAGTTCAAG R CAGCTCCTGCAACTCCTCAA 60 143
Waf1/p21 Murine NM_007669 F TTGTCGCTGTCTTGCACTCT R ATCTGCGCTTGGAGTGATAG 60 124
aTa: annealing temperature;
bSize of the ampliﬁed fragment.
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in ﬁgure legends. Total DNA concentration was balanced
to 30mg/ml with pBS (a minimal vector, Stratagene). Each
transfection was done in duplicate and repeated four to
ﬁve times. Six hours after adding the DNA precipitate, the
cells were washed twice, re-fed with fresh medium and
incubated at 378C for 18h. The cells were then lysed with
200ml/well of passive lysis buﬀer provided with the
‘luciferase assay kit’ (Promega) and proceeded as pre-
viously described using the Microlumat LB96P lumin-
ometer (Berthold EG&G Instrument) (35).
Western blot analysis
Mice tissues were squashed between two glass slides,
dispersed in PBS and centrifuged for 5min at 5000 r.p.m.
at 48C. The pellets were resuspended, at 48C, in 500mlo f
lysis buﬀer [20mM HEPES pH 7.6; 2mM EGTA; 5mM
EDTA; 30mM sodium ﬂuoride; 10mM sodium pyrophos-
phate; 2mM sodium orthovanadate; protease inhibitor
cocktail (Roche); 5mM pepstatin A; 0.5% nonidet P-40).
After sonication, the extracts were centrifuged for 30min
at 68000 r.p.m. at 48C (Beckman TL-100 rotor). Total
protein concentration of the supernatants were deter-
mined by the Bradford assay (Biorad Protein Assay).
A volume of supernatant corresponding to 80mg of total
protein was separated on a 12% SDS–PAGE. After
electrophoresis, the proteins were electrotransferred to
nitrocellulose ﬁlters and the ﬁlters were probed with either
the polyclonal anti-Haeme-oxygenase 1 (M-19) produced
in goat (Santa Cruz Biotechnology, sc-1797; 1:250
dilution) to reveal mouse HO-1 or with the anti-p21
antibody clone SX118 produced in mice (BD Pharmingen,
ref. 556430; 1:500 dilution) or with the anti-actin (20–33)
antibody produced in rabbit (Sigma Aldrich; ref. A5060;
1:500 dilution). After incubation with the secondary
antibody conjugated with horseradish peroxidase diluted
1:10000 [anti-goat peroxidase (Vector) to reveal HO-1;
anti-mouse peroxidase and anti-rabbit peroxidase to
reveal p21/Waf1 and actin, respectively (Santa Cruz
Biotechnology)], detection was performed with
Chemiluminescence Reagent Plus (NEN).
Electrophoretic mobility shiftassays (EMSA)
Wild-type human p53 protein was overexpressed in Sf21
cells using a baculovirus expression vector (36). Oligomers
[TCGAGGAACCAGCCTGAACTAGCCCG/CTAGCG
GGCTAGTTCAGGCTGGTTCC], containing the puta-
tive HO-1 p53RE were annealed and labelled with a
32P
dCTP using Klenow fragment of the DNA Polymerase
and then used as probe. A mix containing 0.5ml p53-
overexpressing Sf9 cellular extract, 3.3mlo f3   buﬀer
[60mM HEPES pH 7.6; 300mM NaCl; 4.5mM MgCl2;
30mM DTT; 0.3% Triton 100X; 3mM Pefabloc
(Boehringer); 60% glycerol); 30ng of puriﬁed anti-p53
antibody PAb 421 (Calbiochem); 100ng of sonicated,
non-denatured, salmon sperm DNA and 0.5ng of radio-
label probe in a ﬁnal volume of 10ml was incubated
for 30min at room temperature. For competition experi-
ments, 100- and 500-fold molar excess of unlabelled
double-stranded oligonucleotides, corresponding to the
consensus (speciﬁc=TCGACGGACATGCCCGGGCA
TGTCCGTCGA annealed to itself) or non-consensus
(non-speciﬁc=GCGGAATTCAAAAGTTAGAGATA
ATCCTACGGGTCGGCCTCGAGGCG annealed to
CGCCTCGAGGCCGACCCGTAGGATTATCTCTAA
CTTTTGAATTCCGC) sequence of p53–DNA-binding
site, were added to the binding reaction before the
addition of the labelled probe. The protein–
32P-DNA
complexes were separated by electrophoresis at 48Co n
4–15% PhastGel (Amersham Pharmacia Biotech) as
previously described (33).
Chromatin immunoprecipitation assays
Fifteen centimetre dishes of subconﬂuent MCF-7 cells
were subjected to ChIP assay as previously described (37).
Brieﬂy, cells were treated with 1% formaldehyde to cross-
link genomic DNA and proteins. Cells were lysed with
SDS-lysis buﬀer containing a protease-inhibitor cocktail
and sonicated to generate DNA fragments 300–800bp
long. Chromatin was immunoprecipitated with the mono-
clonal antibody DO-7, directed against p53 (a gift from Dr
D. Lane) for 16h. Immunoprecipitates produced by anti-
Sin3A(AK-11) (Santa Cruz Biotechnology Inc., sc-767)
served as control. After immunoprecipitation, DNA–
protein cross-links were reversed by incubation at 658C
for 4h and genomic DNA was extracted. The immuno-
precipitated genomic DNA were ampliﬁed with the
oligonucleotide pair GTCAACGCCTGCCTCCTCTC/
GGTTGCGGACGCTCCATC ﬂanking the suspected
binding site of p53 in HO-1, and, as a positive control,
with the oligonucleotide pair GTGGCTCTGATTGGC
TTTCTG/CTGAAAACAGGCAGCCCAAG that ﬂanks
the Waf1/p21 p53RE (38).
RESULTS
Invivo identification of HO-1as anovel p53-inducible gene
Microarray analysis was used to identify genes involved in
oxidative metabolism whose stimulation depends on p53
activation, in vivo. Recently, we showed that 1Gy is the
lowest dose of irradiation to give a signiﬁcant p53-
dependent stimulation of expression of the principal
proapoptotic genes, in the thymus and spleen of whole
body irradiated mice (39). We decided therefore to use this
relative low dose of irradiation to search for oxidant genes
whose expression is regulated in response to p53 activa-
tion. Wt-p53 (p53+/+) and null (p53 / ) mice were
irradiated at a dose of 1Gy and sacriﬁced 6h after
irradiation. Radioactively labelled cDNA was synthesized
from total RNA extracted from the thymus and hybri-
dized to Altas
TM mouse stress/toxicology array mem-
branes as described in the Materials and Methods section.
Among the 140 genes present in the membrane, HO-1
(still referred as Hmox1) is the only one that was found to
be signiﬁcantly up-regulated in response to irradiation in
p53+/+ but not p53 /  mice. According to the
microarray analysis, expression of HO-1 is stimulated by
a factor of 7.5 in the thymus of irradiated p53+/+ mice
compared to non-irradiated mice. Such stimulation is not
observed in the thymus of p53 /  mice (Figure 1A).
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time RT-PCR analysis using the same RNA samples
(Figure 1A). The g-ray induction of HO-1 in p53+/+ but
not in p53 /  mice was conﬁrmed in independent
experiments, both in thymus and spleen of mice subjected
to 5Gy of whole body irradiation (Figure 1B). These
results strongly suggest that the up-regulation of HO-1 in
response to g-irradiation requires a functional p53, at least
in the lymphoid organs.
Identification of aputative p53RE within the5’non-coding
region ofthe mouse HO-1gene
If HO-1 is a true target of p53, one or more p53RE should
exist in this gene. Using an in silico approach developed by
Bourdon et al. (40), we found one potential p53RE
(GAACcAGCCTGAACTAGCCC) in exon 1 of the
mouse HO-1 gene, located 10nt upstream of the ATG
initiation codon (Figure 2A). This sequence contains
a single mismatch only, compared to the consensus
sequence deﬁned by el-Deiry and collaborators (41).
To explore the functionality of this putative p53RE,w e
ﬁrst performed a band shift assay to test whether p53
speciﬁcally binds to this element. An extract of Sf21 cells
overexpressing wt-p53 protein (see Materials and Methods
section) was incubated with a radiolabelled double-strand
oligonucleotide corresponding to the potential p53RE in
presence of anti-p53 PAb421 antibody (Figure 2B, lane 2).
PAb421 activates p53 and led to an increased binding of
this protein to the probe (42). To conﬁrm the speciﬁcity of
the protein–DNA interaction, competition assays were
performed. Addition of a 100- and 500-fold excess of non-
radioactive oligonucleotide devoid of a p53-binding site
did not aﬀect the speciﬁc complex (lanes 3 and 4), while
the formation of this complex was inhibited by 100- and
500-fold excess of unlabelled consensus probe (lanes
5 and 6). This result clearly identiﬁes speciﬁc binding of
p53 to the putative p53RE identiﬁed in the 50non-coding
region of HO-1 gene.
To determine whether p53 can transactivate gene
expression via this element, a 131-bp DNA fragment
containing the response element (Figure 2A) was cloned
into a minimal promoter luciferase reporter gene plasmid
as described in the Materials and Methods section.
Expression of the luciferase gene was analysed under
physiological concentration of p53 by transfecting the
reporter plasmid in either U-2OS or MCF-7, two cell lines
expressing an endogenous wt-p53 that could be activated
by the stress of transfection. Results are presented in
Figure 2C. The luciferase activity was signiﬁcantly higher
when the reporter gene was driven by HO-1 sequence as
compared to the empty vector. The inhibition of luciferase
activity by cotransfecting the reporter plasmid with
the p53 dominant negative form p53DD, strongly suggest
that expression from HO-1 sequence depends on the
wt-p53 expressed in MCF-7 and U-2OS cells. This was
further supported by introducing inactivating mutations
within the p53RE as indicated in Figure 2A. These
mutations abolished the speciﬁc binding of wt-p53 to
DNA (data not shown) and strongly reduced the
transcriptional activity of the HO-1 sequence indepen-
dently of the concentration of the reporter plasmid
transfected in U-2OS cells (Figure 2D).
Taken together these results indicate that p53 could
directly transactivate the mouse HO-1 gene both in vitro
and in vivo.
HO-1 p53RE is conserved between mice, human and rat
An alignment of the exon 1 of HO-1 gene of three species
(mouse, human and rat) revealed marked similarities
between rat, human and mouse sequences in particular
at the level of the p53RE, strongly suggesting that the
p53-dependent transactivation of HO-1 may be conserved
between species (Figure 3A).
To further support this assumption, we investigated
whether if the expression of HO-1 is stimulated in human
Figure 1. Gamma-irradiation induced the expression of HO-1 in
p53+/+ but not in p53 /  mice. (A) Total RNA was extracted from
thymus of p53+/+ and p53 /  mice either non-irradiated or whole
body irradiated at a dose of 1Gy. The thymus was taken 6h post-
irradiation. Hybridization to cDNA arrays of mouse stress/toxicology
genes (AtlasTM ﬁlter arrays, Clontech, Palo Alto, CA, USA) was
performed as described in Materials and Methods section. Signal intensity
was normalized as described in Materials and Methods section. The
normalized signal calculated for the thymus of irradiated mice was
expressed relative to the thymus of non-irradiated mice. Results from
microarray analysis (array) were conﬁrmed by real-time quantitative
RT-PCR as described in Materials and Methods section. The relative
level of HO-1 mRNA measured by RT-PCR was normalized relative to
GAPDH mRNA and the level of stimulation was calculated relative to
non-irradiated animals. (B) HO-1 mRNA induction in thymus and spleen
of mice at3h following whole body irradiation at adose of 5Gy. The level
of HO-1 mRNA estimated by real-time quantitative RT-PCR was
normalized as described below. The graphs represent the mean of four
independent experiments with their respective standard deviation. NI,
non-irradiated mice; IR, irradiated mice.
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endogenous HO-1 gene expression was analysed in two
pairs of cells expressing either a functional or an inactive
form of p53. The ﬁrst series corresponds to the two related
cell lines MCF-7 and MCF7/R-A1 that express wt-p53
and the transcriptional inactive mutant p53R280K,
respectively (32). The second pair corresponds to two
SK-N-SH-derived cell lines, SKNSH-CMVneo that
expresses wt-p53 and SKNSH-DDp53 that overexpresses
the p53DD truncated protein that inhibits the endogenous
p53 transcriptional activity (31). Our unpublished results
revealed that a high irradiation dose of 10Gy is required
to obtain a signiﬁcant stimulation of Bax, a well-
characterized proapoptotic p53 target gene, in SKNSH-
CMVneo cells. Therefore, the subconﬂuent cell cultures
were exposed to a g-irradiation dose of 10Gy, total RNA
was extracted 3h after irradiation and HO-1 mRNA levels
were estimated by quantitative real-time PCR as described
in Materials and Methods section. Results are presented in
Figure 3B. As compared to non-irradiated cells (NI),
irradiation (IR) led to a signiﬁcant increase of HO-1
mRNA levels in both MCF-7 and SKNSH-CMVneo cells
that express wt-p53, but not in their related cell lines,
MCF7/R-A1 and SKNSH-DDp53 defective in functional
p53. These results show that the expression of the human
endogenous HO-1 gene is stimulated in response to an
activation of physiologic levels of wt-p53. It is of interest
to note that a relative high irradiation dose is needed.
Next, we carried out a ChIP assay to ensure that the
human HO-1 gene is directly targeted by endogenous
wt-p53 in MCF-7 cells. Using speciﬁc primers that amplify
a 98-bp DNA fragment that includes the putative p53RE
of the human HO-1 gene, we were able to detect DNA
that was immunoprecipitated by an anti-p53 antibody,
but not by a non-speciﬁc antibody. As a positive control,
a 105-bp DNA fragment that included p53RE identiﬁed in
the p21/Waf1 gene was ampliﬁed from chromatin
immunoprecipitated by the anti-p53 antibody but not by
the control antibody (Figure 3C).
Taken together, these results identify HO1 as a bona ﬁde
p53 target gene both in mice and human cells.
Dose-response and kinetics of HO-1 stimulation in lymphoid
organs of wholebody irradiated mice—comparison to the
stimulation ofp21/Waf1
We have shown previously that the expression of Puma,
an essential mediator of p53-induced apoptosis, is readily
stimulated in the lymphoid organs of mice exposed to
a dose of irradiation as low as 0.1Gy. Moreover,
induction of the major proapoptotic p53 target genes
was observed as early as 1h post-irradiation increasing to
a maximum at 3h (39). We were then interested to
determine the sensitivity of HO-1 stimulation in vivo in
comparison to p21/Waf1, a downstream target of p53 and
an universal inhibitor of cyclin-dependent kinase.
HO-1 is stimulated at higher doses of irradiation than
p21/Waf1. Relative mRNA levels were evaluated by
quantitative real-time RT-PCR, in the thymus and
spleen of p53+/+ mice taken 3h after whole body
irradiation at 0.1, 0.2, 0.5, 1 or 2Gy. From the results
presented in Table 2, it appears that a clear up-regulation
of p21/Waf1 transcription can already be detected at
0.1Gy in spleen and at 0.2Gy in thymus, showing that the
in vivo sensitivity of p21/Waf1 to irradiation is comparable
to that determined previously for the main proapoptotic
genes (39). Nevertheless, the stimulation of HO-1 gene
expression required higher irradiation doses of 0.5Gy in
thymus and of 1Gy in spleen. At higher doses of
irradiation, the stimulation of HO-1 and p21/Waf1 gene
expression reached comparable levels in the thymus but
not in the spleen, where HO-1 was noticeably less induced
than p21/Waf1.
HO-1 gene induction is delayed in relation to
p21/Waf1. Kinetics of HO-1 and p21/Waf1 mRNA
accumulation was measured in the spleens of p53+/+
mice following whole body irradiation at 1Gy. Results are
presented in Figure 4A. The stimulation of p21/Waf1
reached a maximum as soon as 1h after irradiation, while
a signiﬁcant stimulation (2.5 0.3) of HO-1 was detect-
able starting at 3h post-irradiation. Similar results were
obtained while assaying the RNA extracted from thymus
of irradiated mice. As in the spleen, stimulation of
p21/Waf1 is readily detectable at 1h post-irradiation,
while a signiﬁcant stimulation of HO-1 was noticeable at
3h only (data not shown).
Finally, we addressed whether the stimulation of HO-1
transcripts is also reﬂected in a stimulation of HO-1
protein levels. Western blot analysis was performed with
protein extracts prepared from the spleens of mice
subjected to 1Gy of whole body irradiation. As shown
in Figure 4B, the level of the p21/Waf1 protein increased
3h after irradiation, to reach a peak at 6h, and then
declined at 9h. The HO-1 protein was found to increase
6h after irradiation and the increased level was sustained
up to 9h. These results further support the results of
mRNA clearly showing that the stimulation HO-1 gene
expression in response to g-irradiation is delayed com-
pared to p21/Waf1.
DISCUSSION
As more has been learned about p53, it has become
apparent that there is a reaction to nearly every p53 action
leading to an array of autoregulation feedback loops.
The ﬁrst described was the p53-Mdm2 negative feed-
back loop that represents the best-studied relationship
between a tumour suppressor gene, which functions as
a transcription factor and an oncogene. p53, activates
transcription of the Mdm2 gene. Mdm2, once produced,
binds to p53 preventing it from acting as a transcription
factor, and subsequently ubiquitinates it, which enhances
its proteolytic breakdown [review in Oren et al., (43)].
Another example is the role of p53 in the ROS regulation.
As reported in the Introduction section, p53 can activate
numerous genes involved in increased generation of ROS,
which contributes to apoptosis and also functions in
a feedback loop in which ROS can signal to the further
activation of p53. More recent evidence suggests however,
that p53 may also induce the expression of proteins that
Nucleic Acids Research, 2007, Vol. 35, No. 20 6929Figure 2. The mouse HO-1 gene is directly transactivated by p53. (A-a) Sequence of the 50 non-coding region of the mouse HO-1 gene with, in the
open boxes, the putative p53RE that consists of two adjacent decamers that respond to the deﬁnition of a p53-binding site according to El Deiry
et al. (41). Nucleotide numbering starts at the A of the translation initiation codon. The lower case letter within the ﬁrst decamer indicates the variant
nucleotide as compared to the consensus decamer: PuPuPuC(A/T)(A/T)GPyPyPy). The two HindIII and NcoI restriction sites were added by PCR
ampliﬁcation in order to clone this sequence within the pluc.min vector to obtain the pGL3-HO1 reporter gene plasmid (see Materials and Methods
section). (b) Three mutations (underlined lower case letters) have been introduced within the second decamer by PCR-directed mutagenesis. (B)
EMSA shows a speciﬁc binding of baculovirus-produced human wt-p53 to the two decamers identiﬁed in the mouse HO-1 gene.
32P-labelled DNA
probe corresponding to the two decamers was incubated with p53 and the antibody anti-p53 PAb421 (lane2). Competitions were performed by using
100- or 500-fold molar excess of unlabelled double-stranded oligonucleotides either non-speciﬁc (ns, lanes 3 and 4); or homologous (s, lanes 5 and 6),
6930 Nucleic Acids Research, 2007, Vol. 35, No. 20function to lower ROS levels thereby protecting from
oxidative-stress-induced DNA damage and apoptosis
[review by Vousden (44)]. In this vein, we identiﬁed
HO-1 as a direct p53 target gene.
The enzyme encoded by HO-1 belongs to the haeme-
oxygenase family that consists of two constitutive (HO-2
and HO-3) and one inducible (HO-1) isoforms that is also
known as heat shock protein-32 (HSP-32). The haeme-
oxygenase is remarkably conserved from algae to human.
Its substrate, haeme, is the prosthetic group in many
enzymes and proteins that transport, use, store and
detoxify oxygen, such as hemoglobin, catalase and
cytochromes (45). This enzyme catalyses the rate-limiting
degradation of haeme into carbon monoxide (CO), iron
and biliverbin, which is metabolized to bilirubin, and thus
constitutes a major intracellular source of iron and CO.
Although ubiquitously distributed, HO-1 is highly
expressed in the spleen and other tissues that degrade
senescent red blood cells, including specialized reticuloen-
dothelial cells of the liver and bone marrow. In most other
tissues, HO-1 typically occurs at low to undetectable levels
under basal conditions, but its expression is rapidly
activated in response to a number of stimuli that include
haeme, hyperoxia, hypoxia, heavy metals, UV radiation,
H2O2 and nitric oxide. The common characteristic of these
numerous inducers is their ability to cause oxidative stress
(46–48).
HO-1 expression is primary regulated at the transcrip-
tional level. A multiplicity of regulatory elements has been
identiﬁed in the promoter region, in particular speciﬁc
binding sites for the most important regulators of the
cellular stress response such as members of the heat-shock
factor, nuclear factor-kappaB, nuclear factor-erythroid
2 and activator protein-1 (48,49). The presence of a p53RE
within the HO-1 gene was described here for the ﬁrst time.
Early induction of HO-1 expression in response to
whole body irradiation has already been reported in rat
liver (50) and mouse lung (51). But the possible implica-
tion of p53 was not described. Here we reported an early
and dose-dependent stimulation of the HO-1 mRNA level
in thymus and spleen of p53-wt but not of p53-null mice,
in response to whole body irradiation, showing that the
as described in Materials and Methods section. (C) Luciferase assay showed that the transcriptional activity of the 50 non-coding sequence of the
mouse HO-1 gene is stimulated by wt-p53. U-2 OS and MCF-7, two cell lines that express wt-p53, were transfected with either pluc.min (control) or
pGL3-HO1 (HO-1 sequence) and cotransfected with (+DD) or without ( DD) the plasmid pDDm-TO that encodes a dominant negative mutant of
p53. Luciferase activities of cells transfected with pGL3-HO1 were expressed relative to the luciferase activity of cells transfected with pluc.min. The
averaged results are of three independent experiments performed in duplicate. Standard deviations are indicated. (D) mHO-1 p53RE confers the
ability to be transactivated by wt-p53. U-2OS were transfected with either pGL3-HO1 (wt p53RE) or the plasmid pGL3-HO1mut that is mutated
within the p53RE as indicated above (mutant p53RE). Luciferase activities of cells transfected with these two plasmids were expressed relative to the
luciferase activity of cells transfected with pluc.min (control). The averaged results are of four independent experiments performed in duplicate.
Figure 3. The human HO-1 gene is directly transactivated by p53. (A) Alignment of the 50 non-coding sequence of mouse, rat and human HO-1 gene.
In open boxes, the two adjacent decamers that respond to the deﬁnition of El Deiry et al. (41) are shown. The nucleotide variants as compared to the
consensus sequence (see legend of Figure 2) were indicated by lower case letters and nucleotide variations in rat and human p53 decamers as
compared to mouse are underlined. (B) Stimulation of HO-1 gene expression in irradiated human transformed cells expressing wt-p53 (MCF-7 and
SKNSH Neo) but not in cells expressing mutant-p53 (MCF-7/R-A1 and SKNSH DD). Cells were non-irradiated (NI) or irradiated (IR) at a dose of
10Gy. Total RNA was extracted 3h post-irradiation. Expression of HO-1 was analysed by real-time quantitative RT-PCR, normalized relative to
GAPDH mRNA levels and expressed taking as 1 the HO-1 mRNA level of the non-irradiated cells. (C) ChIP assay of HO-1 and Waf1/p21 in MCF-7
cells. Cross-linked p53 protein/DNA complexes were immunoprecipitated with either anti-p53 or anti-mSim3A (negative control) before PCR
ampliﬁcation as described in Materials and Methods section. Input (positive control) indicates a portion of the sonicated chromatin that has been
ampliﬁed after immunoprecipitation.
Nucleic Acids Research, 2007, Vol. 35, No. 20 6931increase of HO-1 mRNA in lymphoid organs of irradiated
mice required the presence of a functional p53.
Vogelstein’s group has already reported a signiﬁcant
induction of HO-1 in colorectal cancer cells forced to
express of wt-p53 (52). However, they have demonstrated
that in cells expressing physiological levels of p53,
stimulation of HO-1 in response to drugs known to
activate p53 such as doxorubicin or 5-ﬂuorouracil, is
comparable in cells expressing either wt- or mutant-p53.
The authors concluded that the induction of HO-1 was
not strictly p53 dependent. The discrepancy between our
results and those of Vogelstein’s group could account for
a diﬀerent cellular context (transformed cell lines in
culture versus in vivo lymphoid cells) and/or the nature
of the induction signal (drug versus g-irradiation). Indeed
we have proven that HO-1 is a direct p53 target gene by
showing that the p53RE identiﬁed within the 50non-coding
region of HO-1 gene binds p53 speciﬁcally, both in vitro
and in vivo.
According to Sablina et al. (53), the p53-inducible genes
can be broadly placed into two groups: those induced
rapidly by low levels of stress (generally cell-cycle arrest
such as Waf1/p21 or antioxidant targets such as SESN1,
SESN2) and those that are induced by higher levels of
stress (generally apoptotic targets such as Puma and
Killer/DR5). These authors propose that the stimulation
of SESN1, SESN2 could protect cells against oxidative
DNA damage and genomic instability under physiologic
condition of stress.
Contrarily to SESN1 and SESN2, stimulation of HO-1
requires a relatively high level of stress, the threshold dose
leading to a signiﬁcant stimulation being even higher for
HO-1 than for p21/Waf1 both in spleen and in thymus
(Table 2). Moreover, induction of HO-1, measured both at
the mRNA and protein levels, is delayed as compared to
p21/Waf1 (Figure 4). Our previous study has revealed
a high in vivo sensitivity of p53-dependent transcriptional
activation of genes involved in the two main apoptotic
pathways, the extrinsic (Fas, Killer/DR5) and the intrinsic
(Bax, Noxa, Puma) ones. As reported here for p21/Waf1,
the expression of these proapoptotic genes was induced as
soon as 1h post-irradiation and reached a maximum at
3h. Moreover, sensitivity of Puma, Bax and Killer/DR5 to
g-irradiation is comparable to that of p21/Waf1. Indeed,
a dose of 0.1Gy of g-irradiation gives a signiﬁcant
stimulation of Puma, and 0.2Gy of g-irradiation induces
a signiﬁcant increase in the expression of Bax and Killer/
DR5 both in thymus and spleen of mice whole body
irradiated. These results show that, in the lymphoid
organs of irradiated mice, genes involved in both cell
cycle arrest and apoptosis respond to p53 activation more
rapidly and at lower dose of irradiation than HO-1. These
results strongly suggest that the physiological function of
the p53-dependent induction of HO-1 diﬀers from that
proposed by Sablina et al. for the other antioxidant p53
target genes (53).
Figure 4. Kinetics of HO-1 and p21/Waf1 stimulation in the spleen of
whole body-irradiated mice. Mice irradiated at a dose of 1Gy were
sacriﬁced at the indicated time post-irradiation. (A) HO-1 and
p21/Waf1 mRNA levels determinate by real-time quantitative RT-
PCR (see Material and Methods section) and normalized relative to
GAPDH mRNA. The graphs represent the mean of four independent
experiments with their respective standard deviation. (B) HO-1 and
p21/Waf1 protein levels analysed by western blot using anti-p21/Waf1,
anti-p53 and anti-actin (to control loading).
Table 2. Dose eﬀect of g-irradiation on the p53-dependent induction of
the HO-1 and Waf1/p21 in thymus and spleen of mice after whole body
irradiation
Organs Gy H0-1 Waf1/p21
Stimulation
  P Stimulation
  P
Thymus 0.1 nd – 1.4 0.15 0.03
0.2 1.8 0.3 <0.05 2.8 1.3 0.01
0.5 3.1 1.1 <0.05 5.4 1.7 <0.001
1 9.7 2.1 <0.005 8.9 3.8 0.001
2 31.3 6.6 <0.005 20.4 6.6 <0.001
Spleen 0.1 nd – 2.5 0.04 <0.0001
0.2 1.2 0.3 ns 3.4 1.1 <0.01
0.5 1.4 0.4 ns 6.0 1.9 <0.005
1 2.3 0.8 <0.05 10.7 5.8 <0.02
2 2.9 0.8 <0.005 16.2 2.9 <0.0001
Three hours following whole body irradiation, mice were sacriﬁced and
total mRNA was extracted from thymus and spleen taken from p53
wild-type (p53+/+) mice exposed to irradiation doses of 0.1, 0.2, 0.5, 1
and 2. Non-irradiated mice were treated in parallel. Transcriptional
induction was evaluated by real-time RT-PCR as described in Materials
and Methods section and expressed relative to mRNA level measured
from non-irradiated mice. One-way ANOVA analysis was used to
determine signiﬁcance between stimulation factors of irradiated versus
non-irradiated mice. A stimulation factor of 2 with a P value <0.05
was considered as showing a signiﬁcant up-regulation of the gene
expression. Asterisk: mean of 4 (thymus) or 5 (spleen) mice mean
deviation; nd=not determined; ns=not signiﬁcant.
6932 Nucleic Acids Research, 2007, Vol. 35, No. 20In addition to its well-characterized role as a metabolic
enzyme specialized in the breakdown of haeme, HO-1
is now generally accepted as a mediator of cyto- and tissue
protection against wide variety of stress (48). The
cytoprotective action of HO-1 seems to be mainly
a function of the antiapoptotic eﬀects of the enzyme.
The antiapoptotic action of HO-1 derived mostly from its
haeme degradation products, including bilirubin, a potent
antioxidant, and CO that has been shown to possess
signalling properties aﬀecting numerous critical cellular
functions including apoptotic cell death (47,48).
Interestingly, Liu et al. report an antiapoptotic role of
CO in vascular smooth muscle treated with a cytokine
mixture that is associated with an inhibition of p53
stimulation and the suppression of cytochrome c release
from mitochondria (54). Interestingly, our results show a
decrease of p21/Waf1 stimulation both at the mRNA and
protein levels, 9h post-irradiation (this study) and of the
proapoptotic p53 target genes, 6h post-irradiation (our
previous published data, 39) in the lymphoid organs of
irradiated mice. On the contrary, no decrease in HO-1
stimulation was noticeable neither at the protein nor at the
mRNA level (Figure 4). This suggests the existence of
a negative feedback loop between the activation of p53
by ROS and the p53-dependent stimulation of HO-1.
According to this hypothesis, increased expression of HO-
1 would reduce intracellular pro-oxidant levels leading to
diminution of p53 activation and consequently a decrease
in p53 target genes stimulation.
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